We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Baxter International Inc (BAX) is a leading medical instruments & supplies business with stocks listed in the US. It opened the day at US$84.25 after a previous close of US$84.09. During the day the price has varied from a low of USD82.115 to a high of USD84.5. The latest price was USD82.24 (25 minute delay). Baxter International is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Baxter International
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Baxter International. Find the share by name or ticker symbol: BAX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Baxter International reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$82.25, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Baxter International, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Baxter International. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Baxter International key stats
- Compare share trading platforms
- Is Baxter International stock a buy or sell?
- Baxter International performance over time
- Can I short Baxter International shares?
- Is Baxter International suitable for ethical investing?
- Are Baxter International shares over-valued?
- Baxter International's financials
- How volatile are Baxter International shares?
- Does Baxter International pay a dividend?
- Have Baxter International shares ever split?
- Other common questions
Baxter International share priceUse our graph to track the performance of BAX stocks over time.
Baxter International shares at a glance
|52-week range||US$74.0624 - US$90.3031|
|50-day moving average||US$84.2663|
|200-day moving average||US$80.9935|
|Dividend yield||US$0.98 (1.19%)|
|Earnings per share (TTM)||US$2.07|
Compare share trading platforms to buy stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Baxter International stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Baxter International price performance over time
|1 week (2021-06-07)||1.21%|
|1 month (2021-05-14)||-1.93%|
|3 months (2021-03-12)||5.49%|
|6 months (2020-12-14)||4.33%|
|1 year (2020-06-12)||-2.06%|
|2 years (2019-06-14)||5.53%|
|3 years (2018-06-14)||9.06%|
|5 years (2016-06-14)||85.06%|
Is Baxter International under- or over-valued?
Valuing Baxter International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Baxter International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Baxter International's P/E ratio
Baxter International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 41x. In other words, Baxter International shares trade at around 41x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Baxter International's PEG ratio
Baxter International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.9515. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Baxter International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Baxter International's EBITDA
Baxter International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$2.7 billion.
The EBITDA is a measure of a Baxter International's overall financial performance and is widely used to measure a its profitability.
Baxter International financials
|Revenue TTM||US$11.8 billion|
|Operating margin TTM||15.58%|
|Gross profit TTM||US$4.7 billion|
|Return on assets TTM||5.97%|
|Return on equity TTM||13.28%|
|Market capitalisation||US$42.3 billion|
TTM: trailing 12 months
Shorting Baxter International shares
There are currently 8.6 million Baxter International shares held short by investors – that's known as Baxter International's "short interest". This figure is 7% down from 9.2 million last month.
There are a few different ways that this level of interest in shorting Baxter International shares can be evaluated.
Baxter International's "short interest ratio" (SIR)
Baxter International's "short interest ratio" (SIR) is the quantity of Baxter International shares currently shorted divided by the average quantity of Baxter International shares traded daily (recently around 2.6 million). Baxter International's SIR currently stands at 3.32. In other words for every 100,000 Baxter International shares traded daily on the market, roughly 3320 shares are currently held short.
However Baxter International's short interest can also be evaluated against the total number of Baxter International shares, or, against the total number of tradable Baxter International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Baxter International's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Baxter International shares in existence, roughly 20 shares are currently held short) or 0.0171% of the tradable shares (for every 100,000 tradable Baxter International shares, roughly 17 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Baxter International.
Find out more about how you can short Baxter International stock.
Baxter International's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Baxter International.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Baxter International's total ESG risk score
Total ESG risk: 24.49
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Baxter International's overall score of 24.49 (as at 12/31/2018) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Baxter International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Baxter International's environmental score
Environmental score: 1.01/100
Baxter International's environmental score of 1.01 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Baxter International's social score
Social score: 16.22/100
Baxter International's social score of 16.22 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Baxter International's governance score
Governance score: 6.28/100
Baxter International's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Baxter International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Baxter International's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Baxter International scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Baxter International hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||24.49|
|Total ESG percentile||47.44|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||3|
Baxter International share dividends
Dividend payout ratio: 33.5% of net profits
Recently Baxter International has paid out, on average, around 33.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.36% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Baxter International shareholders could enjoy a 1.36% return on their shares, in the form of dividend payments. In Baxter International's case, that would currently equate to about $0.98 per share.
While Baxter International's payout ratio might seem fairly standard, it's worth remembering that Baxter International may be investing much of the rest of its net profits in future growth.
Baxter International's most recent dividend payout was on 30 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 2 June 2021 (the "ex-dividend date").
Have Baxter International's shares ever split?
Baxter International's shares were split on a 1841:1000 basis on 30 June 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1841 shares. This wouldn't directly have changed the overall worth of your Baxter International shares – just the quantity. However, indirectly, the new 45.7% lower share price could have impacted the market appetite for Baxter International shares which in turn could have impacted Baxter International's share price.
Baxter International share price volatility
Over the last 12 months, Baxter International's shares have ranged in value from as little as US$74.0624 up to US$90.3031. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Baxter International's is 0.6761. This would suggest that Baxter International's shares are less volatile than average (for this exchange).
Baxter International overview
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Frequently asked questions
Ask an Expert